Mangoceuticals MGRX
NASDAQ MGRX
$0.41 +0.02 (+5.13%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mangoceuticals (MGRX) Other financing activities (2025)

Mangoceuticals' (MGRX) quarterly Other financing activities came in at $297000.0 in Q3 2025, up 98.0% quarter-over-quarter from $150000.0 in Q2 2025.

Analysis

Mangoceuticals (MGRX) Other financing activities (2025) Analysis & Trends

Mangoceuticals has disclosed Other financing activities across 1 years of filings, most recently posting $297000.0 for Q3 2025.

  • In Q3 2025, Other financing activities changed N/A year-over-year to $297000.0; the TTM figure through Dec 2025 stood at $927000.0 (changed N/A YoY), while the FY2025 annual figure was $927000.0, changed N/A from the prior year.
  • Other financing activities came in at $297000.0 for Q3 2025 at Mangoceuticals, up from $150000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $480000.0 in Q1 2025 to a low of $150000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Hinge Health 7.41 Bn 7.03 Bn 183.95 Mn
2 Hims & Hers Health 6.47 Bn 5.63 Bn 480.80 Mn
3 Ethos Technologies 2.54 Bn 2.37 Bn 185.54 Mn
4 Omada Health 1.38 Bn 1.16 Bn 63.79 Mn
5 Teladoc Health 1.14 Bn 366.41 Mn 416.09 Mn
6 Talkspace 870.58 Mn 779.48 Mn 24.80 Mn
7 Akso Health 259.44 Mn 259.25 Mn -
8 LifeMD 147.29 Mn 147.29 Mn -
9 eHealth 31.71 Mn -69.34 Mn -
10 Mangoceuticals 7.39 Mn 7.14 Mn 44,215.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 297,000.00
Jun 30, 2025 150,000.00
Mar 31, 2025 480,000.00